Pcn218 - Personalized Therapy Development in NSCLC Demonstrates Intersection Between Innovation and Positive Coverage Decisions

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nanodiamonds: The Intersection of Nanotechnology, Drug Development, and Personalized Medicine

Science advances
Multidisciplinary
2015English

The Role of Molecular Analyses in the Era of Personalized Therapy for Advanced NSCLC

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2012English

Personalized Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

(Mis)understanding the Intersection Between Development Policies and Data Collection: Experiences in Afghanistan

International Journal of Drug Policy
MedicineHealth Policy
2018English

Personalized Therapy in Breast Cancer

Onkologie
2012English

Personalized and Precision Orthodontic Therapy

Orthodontics and Craniofacial Research
OtorhinolaryngologyOral SurgeryOrthodonticsSurgery
2015English

Personalized Antiplatelet and Anticoagulation Therapy: Pharmacogenomics

Japanese Journal of Thrombosis and Hemostasis
2019English

P1.01-101 Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Digital Pathology in Personalized Cancer Therapy

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy